Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography
- PMID: 20673873
- PMCID: PMC2952433
- DOI: 10.1016/j.biopsych.2010.05.027
Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography
Abstract
Background: Alterations in dopamine D(2)/D(3) receptor binding have been reported in schizophrenia, and a meta-analysis of imaging studies has shown a modest elevation in striatum. Newer radioligands now allow the assessment of these receptors in extrastriatal regions. We used positron emission tomography with [(18)F]fallypride to evaluate D(2)/D(3) receptors in both striatal and extrastriatal regions in schizophrenia.
Methods: Twenty-one patients with schizophrenia and 22 matched healthy control subjects were scanned with an ECAT EXACT HR+ camera. Two-tissue compartment modeling and the reference tissue method gave binding potentials relative to nondisplaceable uptake, total plasma concentration, and free plasma concentration. These were compared between groups in five striatal and eight extrastriatal regions. Several regional volumes were lower in the patient group, and positron emission tomography data were corrected for partial volume effects.
Results: Binding potential values differed in three regions between groups. Values for binding potential relative to nondisplaceable uptake from two-tissue compartment modeling in patients and control subjects, respectively, were 28.7 ± 6.8 and 25.3 ± 4.3 in postcommissural caudate, 2.9 ± .7 and 2.6 ± .4 in thalamus, and 1.8 ± .5 and 2.1 ± .7 in uncus. Loss of D(2)/D(3) receptors with age was found in striatal and extrastriatal regions and was greater in neocortex.
Conclusions: Our study found selective alterations in D(2)/D(3) receptors in striatal and extrastriatal regions, consistent with some but not all previously published reports. As previously shown for the striatum, a more sensitive imaging approach for studying the role of dopamine in the pathophysiology of schizophrenia might be assessment of neurotransmitter levels rather than D(2)/D(3) receptor levels in extrastriatal regions.
Copyright © 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.Neuropsychopharmacology. 2008 Dec;33(13):3111-25. doi: 10.1038/npp.2008.33. Epub 2008 Apr 16. Neuropsychopharmacology. 2008. PMID: 18418366
-
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).J Clin Psychopharmacol. 2008 Dec;28(6):608-17. doi: 10.1097/JCP.0b013e31818ba2f6. J Clin Psychopharmacol. 2008. PMID: 19011428 Clinical Trial.
-
Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.Int J Neuropsychopharmacol. 2010 Aug;13(7):951-60. doi: 10.1017/S1461145710000374. Epub 2010 Apr 15. Int J Neuropsychopharmacol. 2010. PMID: 20392299
-
The role of extrastriatal dopamine D2 receptors in schizophrenia.Biol Psychiatry. 2006 May 15;59(10):919-28. doi: 10.1016/j.biopsych.2006.01.022. Biol Psychiatry. 2006. PMID: 16682269 Review.
-
N-(4-(4-(2-(2-[18F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide.2011 Jun 24 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jun 24 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21994970 Free Books & Documents. Review.
Cited by
-
A neural modeling approach to study mechanisms underlying the heterogeneity of visual spatial frequency sensitivity in schizophrenia.Schizophrenia (Heidelb). 2024 Jul 16;10(1):63. doi: 10.1038/s41537-024-00480-2. Schizophrenia (Heidelb). 2024. PMID: 39013944 Free PMC article.
-
Medial Prefrontal Cortex Dysfunction Mediates Working Memory Deficits in Patients With Schizophrenia.Biol Psychiatry Glob Open Sci. 2022 Oct 26;3(4):990-1002. doi: 10.1016/j.bpsgos.2022.10.003. eCollection 2023 Oct. Biol Psychiatry Glob Open Sci. 2022. PMID: 37881571 Free PMC article.
-
[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans.Eur J Nucl Med Mol Imaging. 2023 May;50(6):1651-1664. doi: 10.1007/s00259-022-06103-1. Epub 2023 Jan 19. Eur J Nucl Med Mol Imaging. 2023. PMID: 36656363 Free PMC article.
-
Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review.Front Psychiatry. 2022 Sep 20;13:925476. doi: 10.3389/fpsyt.2022.925476. eCollection 2022. Front Psychiatry. 2022. PMID: 36203848 Free PMC article. Review.
-
Dopamine and Neuroinflammation in Schizophrenia - Interpreting the Findings from Translocator Protein (18kDa) PET Imaging.Neuropsychiatr Dis Treat. 2021 Nov 18;17:3345-3357. doi: 10.2147/NDT.S334027. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34819729 Free PMC article. Review.
References
-
- Weinberger DR, Laruelle M. Neurochemical and neuropharmacological imaging in schizophrenia. In: Davis KL, Charney DS, Coyle JT, Nemeroff C, editors. Neuropharmacology; The Fifth Generation of Progress; Lippincott: Williams, and Wilkins; 2001. pp. 883–885.
-
- Kessler RM, Whetsell WO, Ansari MS, Votaw JR, de Paulis T, Clanton JA, et al. Identification of extrastriatal dopamine D2 receptors in postmortem human brain with [125I]epidipride. Brain Res. 1993;609:237–343. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials